Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cipla Stays Upbeat On Advair Generic With ‘Superior’ Cost Position, Derisks Abraxane
Outlines Impact Of China Zero-COVID Policy
Nov 10 2022
•
By
Anju Ghangurde
New Revenue Base For Cipla's US business • Source: Shutterstock
More from Earnings
More from Business